A randomised, double-blind controlled clinical trial was conducted in 90 women scheduled for major abdominal gynaecological oncology surgery to determine the effect of adding 0.1% plain bupivacaine to a thoracic epidural fentanyl infusion. Following combined epidural and general anaesthesia, patients were randomised to receive epidural fentanyl 10 p.g/ml, with (group FE) or without (group F) bupivacaine. After an initial 50 p.g bolus of fentanyl, infusion rate was adjusted according to need between 2 and 10 mllhr for 48 hours.
At the time of commencing this study, there were no published double-blind studies comparing epidural fentanyl and fentanyl-bupivacaine infusion after abdominal surgery. It was the aim of this randomised, double-blind study to compare the efficacy and sideeffects of an epidural fentanyl infusion, with and without bupivacaine 0.1 %, after abdominal gynaecological oncology surgery.
METHODS AND MATERIALS
Ninety women scheduled for major abdominal gynaecological oncology surgery via a vertical midline incision extending up to or above the umbilicus were included in this study. Institutional Research and Ethics Committee approval and written informed consent were obtained.
Patients received benzodiazepine premedication and a combined epidural and general anaesthetic technique without concurrent opioid administration. A low thoracic epidural (range T8-T12) was sited by the attending anaesthetist prior to surgery and anaesthesia established to T4 with 0.5% plain bupivacaine. At the completion of surgery a bolus of 50 Jlg of epidural fentanyl in 10 ml normal saline was administered, and in the recovery room an epidural infusion of study solution commenced at 4 mllhr. This solution was prepared in 50 ml coded syringes by the hospital Pharmacy, according to a computer-derived randomisation sequence for two groups. Group F received epidural fentanyl 10 {tg/ml in normal saline and group FB, in addition, 0.1070 bupivacaine. Nursing staff provided boluses of 3 ml (prn hourly) on patient request and were permitted to increment rate by 2 ml (maximum rate 10 mllhr) if a bolus proved inadequate, and to decrement by 2 ml (to a minimum of 2 mllhr) if pain relief was satisfactory and no supplementary boluses had been requested. Patients who felt their analgesia to be unsatisfactory despite dose increments according to the above protocol were withdrawn from the study.
Assessments of pain relief were made both at rest and on movement (sitting up from supine) using visual analogue pain scales at 1, 4, 8, 16, 24, 36 and 48 hours postoperatively. At 24 hours postoperatively an assessment was made of overall postoperative nausea (nil; nausea only; nausea and vomiting) and sedation (nil; drowsy but responsive to command; difficult to rouse). On the morning of the first postoperative day, lower limb strength was graded by rating the worst performance of either lower limb (0= able to maintain a straight leg raise; 1 = unable to maintain straight leg raise, but full hip and knee flexion; 2 = just able to flex hip and knee; 3 = unable to flex knee, normal or reduced ankle movement). The ability to bear weight and walk was assessed on the morning and afternoon of the first postoperative day. Observational monitoring as per hospital protocol for epidural opioid and local anaesthetic administration was used, with additional monitoring and oxygen therapy as clinically indicated. At 48 hours it was noted whether the urinary catheter had been removed and, if so, whether recatheterisation for retention of urine had been required. Drug utilisation for the periods 0-24 and 24-48 hours was recorded.
It was calculated that a final sample size of 84 would detect with 80% probability at a 5% level of significance a difference of 15 mm in mean pain score where the standard deviation was estimated to be 20 mm; and a difference of 20% in grade 1-3 lower limb weakness where the expected incidence in the fentanyl group was zero.
Data, with the exception of age, were not normally distributed and thus were described using median and interquartile range. Wilcoxon rank sum tests were used to estimate differences between the groups for continuous variables and time-adjusted Kruskall-Wallis tests for differences in pain scores between groups over time. Fisher's exact test was used for frequency data. P < 0.05 was considered statistically significant.
RESULTS
Six women initially enrolled had their operative plan altered immediately prior to surgery and were replaced. Of the 90 women commencing the study, ten were excluded due to dislodgement of the epidural catheter (six), failure to follow study protocol (two), and reoperation (two), leaving 80 analysed data sets, 40 in each group. Five of those 80 women withdrew from the study due to dissatisfaction with their analgesia (four group F, one group FB; P=0.36) but, despite incomplete data collection, had relevant data to the time of withdrawal (e.g. pain scores, drug utilisation) included in analyses.
Demographic data
The groups did not differ significantly for patient age, weight or American Society of Anesthesiologists classification (Table 1) . 
Analgesia
Pain scores both at rest and on movement were significantly less in group FB (P=O.OOOl; time-adjusted Kruskall-Wallis test for association between group and pain score), the greatest differences between groups occurring at 4 and 8 hours for pain at rest and 4, 8 and 16 hours with pain on movement (see Figures 1 and 2). Significantly better analgesia was also noted in group FB up to 16 hours postoperatively, when pain scores were analysed in three ordinal groups of 0-20, 20-50, >50 (P<O.OOOl Kruskall-Wallis test).
Postoperative Sequelae
There was no significant difference between groups with respect to the incidence of nausea and vomiting, sedation, pruritis requiring treatment with naloxone or urinary retention (Table 2) .
Postoperative Mobilisation
There was no significant difference between groups in the degree of lower limb weakness experienced on the first postoperative day. Two patients in group F and four in group FB were unable to maintain a straight leg raise and one patient (group FB) had more intense lower limb weakness. Eight patients reported dizziness or lightheadedness on assuming the erect position and were thus unable to walk at that assessment time (seven group FB, one group F; P==O.06 Fisher's exact test). Significantly fewer patients in group FB were able to walk on the morning of the first postoperative day (Table 2) ; however, by the afternoon of the same day all patients in both groups were ambulant.
Drug Utilisation
Significantly more fentanyl was used both on day one and overall by group F. The rates of fentanyl and bupivacaine administration for the study period are shown in Table 3 . Values are median (interquartile range). 
Fentanylbupivacaine

DISCUSSION
Despite the popularity of epidural bupivacainefentanyl infusions for postoperative pain management, the optimum concentrations and dose rates of bupivacaine have not been determined. Furthermore, although a synergistic effect of opioid and local anaesthetic has been demonstrated in animal models and other clinical acute pain settings, several studies have failed to find benefit from, and thus questioned the value of, adding bupivacaine to opioid alone. 5.7·9,15 This study, however, supports those trials in which improved analgesia was obtained at minimal cost in terms of local anaesthetic-induced side-effects. 12 14 Better analgesia both at rest and with movement was demonstrated for most of the first twenty-four hours after major abdominal surgery, and there was a small but statistically significant fentanyl dose-sparing effect when 0.1% bupivacaine was added to a thoracic epidural fentanyl infusion. This was at the expense of a short delay in the postoperative mobilisation of about a third of patients the day following surgery.
Although high concentrations or dose rates of epidural bupivacaine, alone or in combination, can be effective,16,17 the disadvantages conferred by intense motor block and increased toxicity risk make this approach unacceptable, especially when early postoperative mobilisation is important (for example, patients at high risk of thromboembolic complications). As an alternative, combination solutions containing up to 0.2070 bupivacaine, administered at rates of about 10 to 15 mg/hr, have become popular. However, blinded studies using epidural opioids with 0.08-0.1 % bupivacaine have reported no advantage over opioid alone following orthopaedic, abdominal and thoracic surgery. ' ,' ,7.9,11 It has been suggested that 0.1 % bupivacaine is ineffective, even for postoperative visceral pain.9 In contrast, 0.125% combined with diamorphine l7 or sufentaniPS provided superior analgesia to the opioid alone in a double-blind study after abdominal gynaecology surgery and an open study after thoracic surgery. Bupivacaine 0.2% with morphine l3 or fentanyl 12,14 at up to 10 mg/hr also resulted in significantly better pain relief at rest after abdominal vascular and thoracic surgery,12,14 and with patient movement after major abdominal procedures. 13 The failure of several previous studies3.4.711 to show improved pain relief with the addition of bupivacaine may have been due to factors such as (J-error; failure to standardise the type of operation or incision; failure to site the epidural at an appropriate segmental level;
Anaesthesia and Intensive Care, Vol. 22, No, I, February, 1994 methodology which failed to optimise opioid dosage; and failure to assess pain relief during movement. In addition to catheter position, dose and volume rate of both bupivacaine and lipophilic opioid may be important in ensuring adequate dermatomal spread for the operative site; 1' 1.21' unfortunately, in this study, the level of sensory block demonstrable by pinprick was not sought.
As Dahl et al. Il have suggested, the afferent input from the operative field may differ during rest and movement, and systematic evaluation of pain relief on movement (or with coughing) has been lacking in previous studies. Not surprisingly, pain relief at rest is better than during movement, and epidural opioids alone can provide good analgesia at rest'·7.1I but frequently give poor pain relief during physiotherapy or mobilisation. 18 The quality of analgesia in this study was very good in the combination group, as indicated by low median pain scores of similar range to those reported by George et al.,12 i.e. less than 5 at rest and 20 with movement. Although the majority of patients in both groups reported pain scores of less than 30 throughout, a significant proportion scored over 50, especially with movement during the 4 to 24 hr postoperative period. In contrast to this study, Dahl et al. Il found no significant difference in analgesia at rest, but this probably reflects methodological differences (for example, their use of morphine and concurrent piroxicam), or, since pain scores were lower in their combination group, a {3-error. They also found no difference between groups in the first four postoperative hours, probably due to the residual effect of a continuous intraoperative epidural infusion. We detected a significant difference by four hours postoperatively, which probably reflects differing methodology in that epidural anaesthesia was established preoperatively but only supplemented intraoperatively at the anaesthetist's discretion.
Reduction in pain from the addition of bupivacaine was maximal in the 4 to 16 hour period, and continued up to 24 hours postoperatively, as previously reported by other investigators."· 14 . 1X The absence of benefit on the second postoperative day may reflect tachyphylaxis, a fall in pain intensity or an improved analgesic effect from epidural fentanyl.
A second potential advantage from the addition of bupivacaine is a fentanyl dose-sparing effect. Cost benefit aside, this is only of clinical value, however, if opioid-related side-effects or the risk of respiratory depression are reduced. Other studies have found no significant difference in infusion rates or dose requircments, :.'1 although some"·" support our finding that there is a small, but arguably clinically unimportant, reduction in dose requirement of about 20070 . The addition of bupivacaine to epidural fentanyl confers the risk of hypotension, motor block (with potential implications for bladder function and leg strength) and pressure areas due to skin sensory loss. Hypotensive episodes may be in part dose-dependent, and although modest falls in systolic blood pressure may occur with low-dose bupivacaine,12.14 significant hypotension has not been reported with combination infusions including up to 0.2070 bupivacaine. Urinary retention is a recognised complication of epidural opioid administration and previous studies have not found any increase with the addition of bupivacaine. ' 4 . '6 ." The rate of retention is high in uncatheterised patients receiving combination solution after major gynaecological surgery, 17 but in this study the concern of our surgeons that retention of urine after removal of the urinary catheter was bupivacaineinduced proved unfounded. In this female population, who were all catheterised until at least the morning of the first postoperative day, this complication was uncommon and the only cases occurred in those receiving fentanyl alone. A high incidence of lower limb weakness has been reported after epidural bupivacaine 0.1 OJo-fentanyl infusion via a lumbar catheter after casearean section. 6 However, when bupivacaine 0.1 to 0.2070 at a rate of up to 10 mg/hr is administered via a thoracic epidural, demonstrable weakness appears infrequent or absent. ".14 Several study patients were unable to sustain a straight-leg raise in one lower limb. This may have reflected pre-existing weakness or local anaesthetic-induced motor block, the latter possibly a residual effect of intraoperative epidural anaesthesia, since two were not receiving bupivacaine in their infusion. Only one patient in the study had more intense leg weakness (equivalent to a partial Bromage block of 33070).
Nevertheless, although lower limb motor block was minimal or absent in those receiving fentanylbupivacaine, fewer patients in this group could be mobilised on the morning of the first postoperative day. In many cases this appeared to be due to symptoms suggestive of postural hypotension, although this is speculative since postural blood pressure changes were not sought. This problem was, however, short-lived and all patients had become ambulant by the afternoon of the first postoperative day. This is consistent with a study by George and colleagues,'4 who found that, when mobilisation was not attempted until the second postoperative day, no postural hypotension occurred. No patient experienced clinically significant respiratory depression. Although the ventilatory depressant effects of epidural fentanyl are well documented, and there are sporadic case reports of severe respiratory depression, the lattcr has only been reported after large doses and infusions of above 1.5 p.g/kg/hr. 22 In the range 30-70 p.g/hr of epidural fentanyl, as most commonly required in this study, this technique has an excellent clinical safety record.
This study is the first to demonstrate improved analgesia from the addition of only 0.1 070 bupivacaine. In addition, bupivacaine was utilised at a lower rate (about 4 mg/hr) than that of previous studies reporting a beneficial effect. The optimum concentration of bupivacaine remains to be determined, although 0.125% appears to have an equivalent dose-sparing effect to 0.25%21 and thus the evaluation of concentrations of less than 0.1 % may be warranted. The analgesic benefits of additional bupivacaine appear confined to the first 24 hours after abdominal gynaecological oncology surgery, and there would appear to be no advantage in continuing with a combination solution after this time in this population, although other benefits of local anaesthetic-induced neural block may exist in other surgical settings. Since there is a transient delay in the ability to mobilise some patients, if this is a priority on the first postoperative morning consideration should be given to the use of epidural fentanyl alone. Although it remains to be determined whether other benefits exist with regard to postoperative outcome, we consider that the combination of epidural fentanyl and low-dose bupivacaine in the early postoperative period can usually be recommended in this patient population.
